Macrolide Pharmaceuticals Secures $22,000,000 Series A Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e974622e-dd68-47b8-ac7c-0803a23fd72f
Date
3/5/2015
Company Name
Macrolide Pharmaceuticals
Mailing Address
3 Newton Executive Park Newton, MA 02462 USA
Company Description
Macrolide Pharmaceuticals, LLC. is a new anti-infective company founded to advance groundbreaking technology developed by Professor Andrew Myers of Harvard University.
Website
http://www.macrolidepharma.com
Transaction Type
Venture Equity
Transaction Amount
$22,000,000
Transaction Round
Series A
Proceeds Purposes
Proceeds of the financing will enable Macrolide Pharmaceuticals to expand its proprietary drug discovery platform and accelerate the development of a pipeline of novel antibiotics.
M&A Terms
Venture Investor
Venture Investor
Venture Investor